-
Sanyou Bio: Sanyou's Intelligence-Enabled Innovative Biologics R&D Platform Leads in the New Era of Biological Drug Development
28 Mar 2024 18:47 GMT
… and development of innovative biological drugs.
Unique Advantage Brought by System … innovative biologic drugs. Sanyou has built the 4C business patterns that … established friendly business relationships with more than 1000 pharmaceutical companies, drug R…
-
Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential
28 Mar 2024 18:42 GMT
… Directors. "Implementing a lean business model with substantially reduced operating … its partnerships with Pfizer, Boston Pharmaceuticals, and Servier. More specifically:
… expected market share if the drugs are approved and commercialized; uncertainty …
-
Alpha-Pharma.biz review: my experience with legit not-domestic provider
28 Mar 2024 19:14 GMT
So basically, I gotta talk to you guys about one of the best options I’ve found on the market for decent performance-enhancers. I want to give you my advice about finding steroid suppliers like Alpha Pharma Biz.
I’ve been into gear for over a decade now. …
-
Genentech paves path to increased clinical trial diversity as a ‘business imperative’
28 Mar 2024 20:15 GMT
Genentech is aiming to lead the charge for clinical trial diversity in the pharma industry and it’s using a mix of regulatory commitments, trial site partnerships and community activism to get there.
Genentech has already filed …
-
Sickle Cell Disease Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest Drug Approvals | DelveInsight
28 Mar 2024 19:10 GMT
… Blood Therapeutics, is a medication that inhibits the polymerization … each drug.
Moreover, the therapeutics assessment section helps understand the drugs … Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma …
-
Smart Pharmaceutical Factory Technologies Market expected to Witness Huge Revenue Growth to 2031
28 Mar 2024 22:07 GMT
… & Automation), By Application (Drug Discovery & Development, Manufacturing … sectors, including the pharmaceutical industry. Pharmaceutical businesses are encouraged to invest …
Others
By Application-
Drug Discovery and Development
Manufacturing …
-
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
28 Mar 2024 20:05 GMT
FORT WORTH, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film …
-
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
28 Mar 2024 20:28 GMT
… ), a clinical-stage pharmaceutical company, today reported recent business highlights and financial … Program - Upon Investigational New Drug (“IND”) clearance, the Company plans … for patients with cancer. LockBody drug candidates are designed to selectively …
-
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
28 Mar 2024 20:15 GMT
… on promising safety, tolerability, and pharmacokinetic data. In the multiple ascending … kidney diseases. Unicycive’s lead drug candidate, oxylanthanum carbonate (OLC), … product candidates; risks related to business interruptions which could seriously harm …
-
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
28 Mar 2024 20:01 GMT
… financial results and reviewed recent business highlights. “Eledon continues to … safety and efficacy of our drug candidates; risks relating to … jurban@berrypr.com Source: Eledon Pharmaceuticals
ELEDON PHARMACEUTICALS, INC.
CONSOLIDATED BALANCE SHEETS …